Centene Corp (CNC)

Currency in USD
52.98
-0.58(-1.08%)
Closed·
53.60+0.62(+1.17%)
·
CNC is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
52.8754.75
52 wk Range
25.0864.15
Key Statistics
Prev. Close
52.98
Open
53.49
Day's Range
52.87-54.75
52 wk Range
25.08-64.15
Volume
5.03M
Average Volume (3m)
6.62M
1-Year Change
-11.2265%
Book Value / Share
43.57
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CNC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
53.12
Upside
+0.26%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Centene Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Analyst Ratings

7 Buy
12 Hold
1 Sell
Ratings:
20 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 53.12
(+0.26% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Bernstein SocGen Group
Buy68.00+28.35%48.00MaintainMay 05, 2026
TD Cowen
Hold47.00-11.29%38.00MaintainMay 01, 2026
Wells Fargo
Hold56.00+5.70%44.00MaintainMay 01, 2026
Baird
Hold46.00-13.17%37.00MaintainApr 30, 2026
UBS
Hold55.00+3.81%42.00MaintainApr 29, 2026

Centene Corp SWOT Analysis


Market Volatility
Centene faces challenges in ACA Marketplace and Medicaid, withdrawing 2025 guidance amid rising healthcare costs and regulatory uncertainties
Strategic Positioning
Explore Centene's diversified portfolio across government-sponsored healthcare programs and its potential for growth in Medicare Advantage
Financial Outlook
Analysts revise price targets, ranging from $30 to $90, reflecting varied perspectives on Centene's profitability and growth potential
Competitive Edge
Delve into Centene's market leadership in Medicaid managed care and its strategies to navigate industry-wide challenges in risk pool management
Read full SWOT analysis

Centene Corp Earnings Call Summary for Q1/2026

  • Centene Q1 2026 EPS of $3.37 beat forecast by 58%, while revenue of $49.94B exceeded expectations by 5%; stock rose 6% pre-market
  • Full-year 2026 EPS guidance raised to above $3.40 from $3.00; premium revenue guidance increased $1B driven by Texas Medicaid expansion
  • Health Benefit Ratio reported at 87.3%; SG&A expense ratio improved to 7.6% from 7.9% year-over-year, reflecting enhanced cost management
  • Strategic focus on Medicaid and Medicare Advantage segments drove growth; trend management initiatives and clinical programs yielded strong results
  • Key risks include potential healthcare policy changes, economic uncertainties affecting government funding, and intensifying sector competition
Last Updated: 28/04/2026, 14:58
Read Full Transcript

Earnings

Latest Release
Apr 28, 2026
EPS / Forecast
3.37 / 2.13
Revenue / Forecast
49.94B / 47.58B
EPS Revisions
Last 90 days

CNC Income Statement

Compare CNC to Peers and Sector

Metrics to compare
CNC
Peers
Sector
Relationship
P/E Ratio
−4.1x−1.1x−0.5x
PEG Ratio
0.010.350.00
Price/Book
1.2x4.1x2.6x
Price / LTM Sales
0.1x0.9x3.2x
Upside (Analyst Target)
−1.0%19.4%47.8%
Fair Value Upside
Unlock14.0%5.9%Unlock

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
211.68M42.87%11.21B
Other Institutional Investors
273.98M55.49%14.52B
Public Companies & Retail Investors
8.12M1.64%429.96M
Total
493.77M100.00%26.16B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
The Vanguard Group, Inc.11.54%56,978,7533,018,734
BlackRock, Inc.8.98%44,350,6152,349,696

People Also Watch

51.87
CTSH
+0.02%
92.14
QLYS
-0.38%
149.49
IT
+1.21%
558.60
NOC
-1.48%
149.29
ENTG
+7.43%

FAQ

What Is the Centene (CNC) Stock Price Today?

The Centene stock price today is 52.98 USD.

What Stock Exchange Does Centene Trade On?

Centene is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Centene?

The stock symbol for Centene is "CNC."

What Is the Centene (CNC) Afterhours Price Today? (Afterhours variable test: 53.60) Current Date: May 06, 2026

After hours price: 53.60. After hours price change (units): 0.62. Price change percentage: 1.17%

What Is the Centene Market Cap?

As of today, Centene market cap is 26.16B USD.

What Is Centene's Earnings Per Share (TTM)?

The Centene EPS (TTM) is -13.10.

When Is the Next Centene Earnings Date?

Centene will release its next earnings report on Jul 28, 2026.

From a Technical Analysis Perspective, Is CNC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Centene Stock Split?

Centene has split 4 times.

How Many Employees Does Centene Have?

Centene has 61100 employees.

What is the current trading status of Centene (CNC)?

As of May 06, 2026, Centene (CNC) is trading at a price of 52.98 USD, with a previous close of 52.98 USD. The stock has fluctuated within a day range of 52.87 USD to 54.75 USD, while its 52-week range spans from 25.08 USD to 64.15 USD.

What Is Centene (CNC) Price Target According to Analysts?

The average 12-month price target for Centene is 53.12 USD, with a high estimate of 70 USD and a low estimate of 40 USD. 7 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +0.26% Upside potential.

What Is the CNC After Hours Price?

CNC's last after hours stock price is 53.60 USD, the stock has decreased by 0.62, or 1.17%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.